文献
J-GLOBAL ID:202202264880515193
整理番号:22A1050699
新規血漿糖蛋白質バイオマーカーは外科的に切除した明細胞腎細胞癌における進行のない生存を予測する【JST・京大機械翻訳】
Novel plasma glycoprotein biomarkers predict progression-free survival in surgically resected clear cell renal cell carcinoma
著者 (11件):
Serie Daniel J.
(InterVenn Biosciences, San Francisco, CA)
,
Myers Amanda A.
(Department of Urology, Mayo Clinic Florida, Jacksonville, FL)
,
Haehn Daniela A.
(Department of Urology, Mayo Clinic Florida, Jacksonville, FL)
,
Parker Alexander S.
(University of Florida College of Medicine - Jacksonville, Jacksonville, FL)
,
Bajalia Essa M.
(Department of Urology, Mayo Clinic Florida, Jacksonville, FL)
,
Gonzalez Giovanni A.
(Department of Urology, Mayo Clinic Florida, Jacksonville, FL)
,
Li Qiongyu
(InterVenn Biosciences, San Francisco, CA)
,
Wong Maurice Yu
(InterVenn Biosciences, San Francisco, CA)
,
Moser Kaitlynn C.
(InterVenn Biosciences, San Francisco, CA)
,
Zhou Bo
(InterVenn Biosciences, San Francisco, CA)
,
Thiel David D.
(Department of Urology, Mayo Clinic Florida, Jacksonville, FL)
資料名:
Urologic Oncology: Seminars and Original Investigations
(Urologic Oncology: Seminars and Original Investigations)
巻:
40
号:
4
ページ:
168.e11-168.e19
発行年:
2022年
JST資料番号:
W3220A
ISSN:
1078-1439
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)